<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03468920</url>
  </required_header>
  <id_info>
    <org_study_id>17-114</org_study_id>
    <nct_id>NCT03468920</nct_id>
  </id_info>
  <brief_title>Preoperative IV Versus Oral Acetaminophen</brief_title>
  <official_title>Comparison of Outcomes When Patients Receive Preoperative IV Acetaminophen Versus Preoperative Oral Acetaminophen</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TriHealth Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TriHealth Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current study proposes to examine whether there is a significant difference in patient
      outcomes related to the administration route of preoperative Acetaminophen. Specifically, the
      study will compare outcomes of surgical patients who receive IV Acetaminophen with surgical
      patients who receive oral Acetaminophen.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will use a randomized, double-blind, controlled design with two arms:

      Arm 1: Scheduled IV Acetaminophen and PO placebo provided preoperatively Arm 2: Scheduled PO
      Acetaminophen and IV placebo provided preoperatively

      120 patients will be randomized 1:1 into Arm 1 or Arm 2. All other care, except route of
      preoperative Acetaminophen, will follow standard care procedures. The following outcome
      measures will be collected: postoperative pain, postoperative opioid medication
      administration, postoperative nausea and vomiting, occurrence of respiratory depression
      postoperatively, occurrence of administration of reversal agent postoperatively, length of
      stay in recovery room, patient satisfaction with pain control.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Anticipated">March 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This study will use a randomized, double-blind, placebo controlled design with two arms.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Only pharmacy staff will have randomization scheme and be aware of whether patient received oral Acetaminophen with IV placebo OR if the patient received IV Acetaminophen with oral placebo</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>through study visit, less than 24 hours</time_frame>
    <description>Pain measured from 0 (no pain) to 10 (worst pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid administration</measure>
    <time_frame>through study visit, less than 24 hours</time_frame>
    <description>Dose of opioid medication administered</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>through study visit, less than 24 hours</time_frame>
    <description>Negative effects of pain medication (postoperative nausea and vomiting, respiratory depression, and need for reversal agents)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>through study visit, less than 24 hours</time_frame>
    <description>Length of patient stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction</measure>
    <time_frame>up to 2 days after surgery</time_frame>
    <description>Patient reported satisfaction with pain control on a scale of 1 (extremely unsatisfied) to 10 (extremely satisfied)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Arm 1: IV Acetaminophen group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to Arm 1 will receive IV Acetaminophen 1000mg in 100mL NS once and a PO placebo pill preoperatively</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2: PO Acetaminophen group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to Arm 2 will receive IV normal saline 100mL once and Acetaminophen 1000 mg PO once preoperatively</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV Acetaminophen</intervention_name>
    <description>IV Acetaminophen 1000mg in 100mL normal saline once pre-operatively</description>
    <arm_group_label>Arm 1: IV Acetaminophen group</arm_group_label>
    <other_name>Tylenol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PO Acetaminophen</intervention_name>
    <description>Acetaminophen PO 1000mg once pre-operatively</description>
    <arm_group_label>Arm 2: PO Acetaminophen group</arm_group_label>
    <other_name>Tylenol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PO Placebo</intervention_name>
    <description>PO placebo capsule compounded to match PO Acetaminophen capsule</description>
    <arm_group_label>Arm 1: IV Acetaminophen group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV Solution Placebo</intervention_name>
    <description>This will serve as the placebo for the IV Acetaminophen intervention</description>
    <arm_group_label>Arm 2: PO Acetaminophen group</arm_group_label>
    <other_name>IV Normal Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years old or older

          -  Admitted to Bethesda Butler Main Perioperative Services for an outpatient surgical
             procedure performed under general anesthesia

        Exclusion Criteria:

          -  Allergy to Acetaminophen

          -  Lactose intolerance or lactose allergy (placebo capsules contain lactose)

          -  Hepatic disease

          -  Having taken a product containing acetaminophen within 6 hours of scheduled surgery
             time

          -  Pregnant

          -  Weight less than 50kg

          -  Opioid addiction - admits to current opioid addiction and/or substance abuse disorder,
             and/or currently in treatment for opioid addiction or substance abuse

          -  Emergent or on-call procedures

          -  Inpatient surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Diana Pelzer</last_name>
    <phone>513-893-8138</phone>
    <email>Diana_Pelzer@trihealth.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rachel Baker, PhD, RN</last_name>
    <phone>513-569-6191</phone>
    <email>Rachel_Baker2@trihealth.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>TriHealth, Bethesda Butler Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45011</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Baker, PhD, RN</last_name>
      <phone>513-569-6191</phone>
      <email>Rachel_Baker2@trihealth.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2018</study_first_submitted>
  <study_first_submitted_qc>March 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2018</study_first_posted>
  <last_update_submitted>May 10, 2018</last_update_submitted>
  <last_update_submitted_qc>May 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>TriHealth Inc.</investigator_affiliation>
    <investigator_full_name>Rachel Baker</investigator_full_name>
    <investigator_title>Nurse Researcher</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

